Related Experiment Video
Updated: Jun 1, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis
Xiu-Qi Chen1, Lin-Lin Wang, Qing-Wen Shan
1Department of Pediatrics, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Insights
A novel NR1H4 gene mutation (R176X) was identified in one infant with idiopathic infantile cholestasis. This genetic finding aids in diagnosing and understanding the prognosis of this liver disease in infants.
Area of Science:
- Genetics
- Pediatric Hepatology
- Molecular Biology
Background:
- Idiopathic infantile cholestasis (IIC) is a serious liver condition in infants.
- Genetic factors are implicated in IIC pathogenesis.
- The NR1H4 gene's role in IIC requires further investigation.
Purpose of the Study:
- To investigate the genetic contribution of the NR1H4 gene to the development of IIC.
- To identify potential genetic markers for IIC in a Chinese population.
Main Methods:
- Genomic DNA was extracted from 78 IIC patients and 95 controls.
- Polymerase chain reaction (PCR) and single-strand conformation polymorphism (SSCP) were used to analyze NR1H4 gene exons.
- PCR products with abnormal bands were sequenced.
Main Results:
- A novel heterozygous termination codon mutation, NR1H4 R176X (CGA-TGA), was identified in one IIC patient.
- The patient with the R176X mutation exhibited severe liver dysfunction, including high bilirubin, ALT, GGT, cirrhosis, and ascites.
- No NR1H4 mutations were detected in other patients or controls.
Conclusions:
- A heterozygous termination codon mutation in NR1H4 (R176X) is associated with IIC.
- This novel mutation provides a characteristic marker for differential diagnosis of IIC.
- The NR1H4 R176X mutation may influence the prognosis of IIC.
Background:
This study aimed to evaluate the genetic effect of the NR1H4 gene in the pathogenesis of idiopathic infantile cholestasis of Chinese subjects in Guangxi, China.
Methods:
Seventy-eight patients with idiopathic infantile cholestasis served as a study group and 95 infants without cholestasis as controls. Genomic DNA was extracted from peripheral venous blood leucocytes by phenol chloroform procedures. Polymerase chain reaction (PCR) was used to amplify all coded exons of NR1H4, and single-strand conformation polymorphism (SSCP) was used to analyze all amplification fragments. The PCR products with abnormal bands in SSCP were sequenced using an ABI 3100 sequencer.
Results:
A novel heterozygous termination codon mutation in NR1H4 exon 5 (NR1H4 R176X, CGA-TGA) was found in one of the 78 patients. The patient with mutation R176X had high levels of bilirubin, alanine aminotransferase, γ-glutamyltransferase, cirrhosis and ascites despite biliary tract flushing procedures and drug therapy. In the other patients and controls, no mutation was detected.
Conclusions:
Heterozygous termination codon mutation of NR1H4 R176X was found in idiopathic infantile cholestasis. The novel mutation is useful to establish particular characteristics for differential diagnosis of idiopathic infantile cholestasis and to determine the influence of such gene defects in the prognosis.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Inborn Errors of Metabolism
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations
Huntington Disease l: Introduction